Table 4 Comparison of changes in outcome measurements between patients who received Dangguixu-san and those who received placebo for acute lateral ankle sprain (n = 23 each)
From: Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial
Dependent variables | Group (n) | Difference (w1–w0) | Z (p)a | Difference (w5–w0) | Z (p)a | Difference (w5–w1) | Z (p)a |
|---|---|---|---|---|---|---|---|
VAS of pain | DS (n = 23) | 19.91 ± 21.62 | − 0.82 (0.412) | 32.13 ± 23.65 | − 0.63 (0.527) | 12.22 ± 22.08 | − 2.59 (0.010) |
Placebo (n = 23) | 24.78 ± 12.83 | 29.17 ± 16.26 | 4.39 ± 10.71 | ||||
Degree of edema | DS (n = 23) | 0.44 ± 0.93 | − 0.66 (0.512) | 0.45 ± 0.83 | − 0.09 (0.929) | 0.01 ± 0.59 | − 0.96 (0.338) |
Placebo (n = 23) | 0.24 ± 0.53 | 0.40 ± 0.70 | 0.15 ± 0.61 | ||||
Total EQ-5D-5L | DS (n = 23) | 2.13 ± 2.69 | − 0.51 (0.609) | 3.78 ± 4.22 | − 0.48 (0.633) | 1.65 ± 4.13 | − 1.29 (0.198) |
Placebo (n = 23) | 2.57 ± 1.78 | 3.52 ± 2.84 | 0.96 ± 2.14 | ||||
Total FAOS | DS (n = 23) | 61.13 ± 72.52 | − 0.91 (0.362) | 122.66 ± 107.34 | − 0.41 (0.684) | 61.53 ± 99.49 | − 1.15 (0.249) |
Placebo (n = 23) | 83.91 ± 74.37 | 128.46 ± 85.78 | 44.55 ± 53.31 | ||||
FAOS Symptom/Rigidity | DS (n = 23) | 8.36 ± 15.97 | − 1.42 (0.155) | 20.16 ± 21.87 | − 0.08 (0.939) | 11.80 ± 17.34 | − 2.54 (0.011) |
Placebo (n = 23) | 14.69 ± 12.83 | 18.74 ± 17.07 | 4.05 ± 10.47 | ||||
FAOS ache | DS (n = 23) | 15.52 ± 14.41 | − 0.80 (0.426) | 29.29 ± 22.83 | − 1.01 (0.312) | 14.25 ± 20.91 | − 2.69 (0.007) |
Placebo (n = 23) | 18.60 ± 16.60 | 24.41 ± 18.33 | 5.81 ± 10.12 |